Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A person has been diagnosed with triple-negative breast cancer (TNBC), confirmed by a tissue biopsy, and the tumour can be measured by ultrasound.
- The cancer is at a specific stage — either a tumour sized T1c with some lymph node involvement (N1–2), or a tumour sized T2–4 with or without lymph node involvement (N0–2).
- The treating doctor has determined that the person is suitable for a specific combination of chemotherapy and immunotherapy drugs used in this trial.
- Treatment is aimed at curing the cancer, and the person is expected to live for at least 3 months.
- Women who could become pregnant must be willing to use a reliable form of contraception throughout the study and for either 12 months or 6 months after the last dose of treatment, depending on which drugs were received.
- The person has sufficient German language skills to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- A person who has had another invasive cancer within the last 2 years, except for certain treated skin cancers or cervical cancer that has not spread.
- A person who has previously received any systemic (whole-body) treatment for TNBC.
- A person who has a medical condition that prevents them from doing physical activity, such as: severe heart failure; breathing problems that cause partial or complete respiratory failure; a persistently very low platelet count (a blood clotting cell), such as from a treatment-resistant immune condition; or inherited or acquired problems with blood clotting.
- A person with active, symptomatic coronary heart disease (a clearance certificate is required, and additional heart tests may be needed).
- A person who is already taking part in another exercise-based research study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Freerk T Baumann, PhD, University Hospital of Cologne
Phone: 0221-478-42649
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete remission of the tumor (pCR);
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.